Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

UNITBTC

(UNITBTC)

Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
06/01/202411:23AMPR Newswire (Canada)Unifor members begin strike at Gibraltar copper mine
06/01/202411:00AMPR Newswire (US)ICECO Launches APL35 on Indiegogo - The World's Lightest Aluminum Dual-Zone Freezer
06/01/202410:34AMPR Newswire (US)The Agency's Agents Named Among Top Producers in the Country by RealTrends + Tom Ferry The Thousand 2024
06/01/202410:04AMPR Newswire (Canada)Déclaration des ministres Gary Anandasangaree, Patty Hajdu, Dan Vandal et Pascale St-Onge à l'occasion du Mois national de l'histoire autochtone
06/01/202410:00AMGlobeNewswire Inc.Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)TG:GE9Genmab AS
06/01/202410:00AMBusiness WireInvestigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)NASDAQ:GMABGenmab AS
06/01/202410:00AMBusiness Wire"Experience the Luxury of Japanese Tradition and Cuisine" Reservations for the New Inbound Experience Tour in Osaka's Tondabayashi Begin on June 1, 2024!
06/01/202410:00AMBusiness WireInvestigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)NASDAQ:BNTXBioNTech SE
06/01/202410:00AMGlobeNewswire Inc.Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)NASDAQ:BNTXBioNTech SE
06/01/202410:00AMGlobeNewswire Inc.Phase-2-Daten für Prüfpräparat Acasunlimab (DuoBody® -PD-L1x4-1BB) in Kombination mit Pembrolizumab: Signifikante klinische Aktivität bei vorbehandeltem, metastasiertem nicht-kleinzelligem LungenkarzinomXE:22UABioNTech SE
06/01/202410:00AMGlobeNewswire Inc.Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)TG:22UABioNTech SE
06/01/202410:00AMGlobeNewswire Inc.Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Glioblastoma at 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:BDTXBlack Diamond Therapeutics Inc
06/01/202410:00AMGlobeNewswire Inc.Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)XE:22UABioNTech SE
06/01/202410:00AMGlobeNewswire Inc.Phase-2-Daten für Prüfpräparat Acasunlimab (DuoBody® -PD-L1x4-1BB) in Kombination mit Pembrolizumab: Signifikante klinische Aktivität bei vorbehandeltem, metastasiertem nicht-kleinzelligem LungenkarzinomTG:22UABioNTech SE
06/01/202410:00AMBusiness WireFirst Ascent Biomedical Presents Findings from Clinical Studies in Pediatric and Adult Cancers Using its AI-Enhanced Functional Precision Medicine Platform at ASCO 2024
06/01/202410:00AMPR Newswire (US)Tag along with Jason in Zhengzhou: Experiencing Kung Fu at the Shaolin Temple
06/01/20249:53AMPR Newswire (Canada)Statement from Ministers Gary Anandasangaree, Patty Hajdu, Dan Vandal, and Pascale St-Onge on National Indigenous History Month
06/01/20249:30AMBusiness WireTempus Announces Expansion of Collaboration with AstraZeneca to Leverage Tempus Next to Support Guideline-directed Biomarker Testing in NSCLC
06/01/20249:30AMPR Newswire (Canada)Message from the Governor General on Pride Month
06/01/20249:30AMPR Newswire (US)FractIt Revolutionizes Real Estate: Completes Pilot with Tokenization of Luxury Property on Blockchain
06/01/20249:30AMPR Newswire (Canada)Message de la gouverneure générale à l'occasion du Mois de la fierté
06/01/20249:15AMBusiness WireオムディアのRANベンダー・レポートでマべニアがトップに輝く
06/01/20249:14AMGlobeNewswire Inc.Flash News: OKX Announces Position Tier Adjustments for TURBO/USDT Perpetual Futures Listing
06/01/20249:00AMBusiness WireAnkyra Therapeutics Announces Trial in Progress Poster Presentation at 2024 ASCO Meeting and Approval of ANK-101 Phase 1 Protocol Amendment
06/01/20249:00AMBusiness WireSally Hansen® and GLAAD Reprise Their Partnership for the 6th Year With a Launch That Celebrates the LGBTQ+ Community
06/01/20249:00AMPR Newswire (Canada)Statement by Minister Khera on Italian Heritage Month
06/01/20249:00AMPR Newswire (US)Vincent Todd Announces the Introduction of Todd Agriscience
06/01/20249:00AMPR Newswire (US)Beverly Hills MD Celebrates Its 10th Anniversary
06/01/20249:00AMPR Newswire (Canada)Déclaration de la ministre Khera à l'occasion du Mois du patrimoine italien
06/01/20249:00AMPR Newswire (US)American Cancer Society and American Society of Clinical Oncology Unite to Create One of the Largest and Most Comprehensive Online Sources of Credible Cancer Information